𝔖 Bobbio Scriptorium
✦   LIBER   ✦

P-18 SCORING BASED ON FLOWCYTOMETRIC ANALYTIC DATA OF THE PATIENTS WITH A CLINICAL DIAGNOSIS OF CHRONIC LYMPHOCYTIC LEUKEMIA

✍ Scribed by E. Uzer; A. Unal; M. Cetin; B. Eser; M.Y. Koker

Book ID
119612939
Publisher
Elsevier Science
Year
2012
Tongue
English
Weight
61 KB
Volume
47
Category
Article
ISSN
1473-0502

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

The National Cancer Data Base Report on
The National Cancer Data Base Report on age, gender, treatment, and outcomes of patients with chronic lymphocytic leukemia
✍ Louis F. Diehl; Lucy Hynds Karnell; Herman R. Menck πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 173 KB πŸ‘ 2 views

The natural history of chronic lymphocytic leukemia (CLL) is changing, although the reasons (potential changes in the disease's biology or in patterns in patient characteristics, treatment, or referral) are unclear. ## METHODS. This report uses National Cancer Data Base (NCDB) data, which reflect

Routine clinical use of alemtuzumab in p
Routine clinical use of alemtuzumab in patients with heavily pretreated B-cell chronic lymphocytic leukemia : A nation-wide retrospective study in Austria
✍ Michael Fiegl; Andreas Falkner; Georg Hopfinger; Stefan Brugger; August Zabernig πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 250 KB πŸ‘ 1 views

## Abstract ## BACKGROUND. In previous studies, alemtuzumab demonstrated considerable activity in patients with previously treated B‐cell chronic lymphocytic leukemia (CLL), including fludarabine‐refractory disease. In this retrospective study, the authors evaluated the benefit of alemtuzumab mono